COMMUNIQUÉS West-GlobeNewswire

Alpha Tau to Participate in October Investor Conferences
05/10/2026
JERUSALEM, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
Transactions under Novonesis’ share buyback program
05/10/2026
Please read the announcement in PDF Attachment 2026_20_Share_buyback
Research Peptide Companies: Kylo Peptides Scores 96.7/100 in Plastic Surgery Key Review
05/10/2026
Sheridan, Wyoming, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides https://kylopeptides.com/ [], a U.S.-based supplier of research-use-only peptides, has received a score of 96.7/100 in a Plastic Surgery Key review of [...]
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
05/10/2026
– ABI-6250's pharmacodynamic analysis was recognized as a Poster of Distinction – SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company [...]
Medicovestor Announces FDA IND Clearance for MC001, Advancing to An International Phase 1 Study
05/10/2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Medicovestor, Inc. today announced FDA clearance of its Investigational New Drug (IND) application for MC001, the Company's first-in-class dimeric chemoimmunotherapy ADC for [...]
Ostia Sciences Publishes Second International Patent Application Covering the Sorbitol Switch That Drives Production of Phosphorylated Lantibiotics
05/10/2026
WO 2026/178627 covers methods, uses and compositions pairing Streptococcus salivarius SALI-10 with sorbitol, creating a synbiotic system designed to support the strain and increase production of its phosphorylated [...]
Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026
05/10/2026
Recognized for bold approach to addressing therapeutic targets WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for [...]
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
05/10/2026
Two oral presentations at AHA Hypertension 2026 will highlight the substantial antihypertensive efficacy of aprocitentan in two hypertension populations from the PRECISION study: patients with obesity and patients [...]
Déclaration d’actions et de droits de vote - Statut au 30 septembre 2026
05/10/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 30 septembre 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège [...]
Declaration of shares and voting rights - Status as of September 30, 2026
05/10/2026
VALNEVA Declaration of shares and voting rights Status as of September 30, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot [...]
Global Alzheimer's Platform Foundation Names New Medical Director at Tampa Research Site
05/10/2026
WASHINGTON, D. C. , Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform Foundation ® (GAP), announced today that Dr. Jeffery Greenberg is joining GAP as the Medical Director and Principal Investigator of [...]
Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026)
05/10/2026
Company announcement No. 53 / 2026 Zealand Pharma - Completion of share buy-back program and related transactions (week 40 and 41, 2026) Copenhagen, Denmark, October 5, 2026 – Zealand Pharma A/S ("the Company" or “ [...]
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
05/10/2026
The BB-301 pivotal trial remains on track to begin in mid-2027 Discussions regarding an open-label, single-arm, pivotal study for BB-301 are ongoing, and based on these discussions, the FDA requested additional [...]
MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy
05/10/2026
Collaboration will increase access to practitioner education in the United States and internationally Partnership brings experienced psychedelic-assisted therapy practitioners together to guide the next generation of [...]
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer
05/10/2026
REDWOOD CITY, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for [...]
Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
05/10/2026
Quarter included presentation at H.C. Wainwright Global Investment Conference, strategic partnership with Alpmed, new regulatory registrations, and continued physician training NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE [...]
4DMT to Host Investor Day on October 21, 2026
05/10/2026
Company to share insights on the advancing clinical profile and commercial vision for 4D-150 Renowned retinal experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Carl C. Awh, MD, FASRS; Dr. David Eichenbaum, MD, FASRS; [...]
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
05/10/2026
Dr. Eckler brings more than two decades of combined experience in healthcare investing across public and private markets at Samsara BioCapital, ArrowMark, and GMT Capital, and scientific research Company planning NDA [...]
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
05/10/2026
Multi-year expansion of the companies’ 2025 agreement to use Gate’s Molecular Gate drug discovery engine to design molecular gate medicines for Lilly targets BRISBANE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Gate [...]

Pages